Kos Biotechnology Partners and FORTH Unite to Propel Greek Biotech Innovation Forward

Kos Biotechnology Partners and FORTH Unite to Propel Greek Biotech Innovation Forward



In a recent announcement that has sent waves through the biotech community, Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) have entered a strategic partnership, formalized through a Memorandum of Understanding (MOU). This collaboration aims to establish a state-of-the-art life sciences incubator on FORTH's campus in Heraklion, Crete. The commitment is not just to support existing biotech firms but to create a nurturing environment for innovative life sciences startups from across the globe.

The Kos/FORTH initiative aspires to build a global hub that caters to both emerging and established biotechnology companies hailing from the United States, Europe, China, and Israel. The incubator will offer access to top-tier laboratory services, cutting-edge equipment, specialized research capabilities, and invaluable scientific consultancy. This ecosystem is designed to fast-track research and development efforts, putting Greece on the map as a significant player in the realm of biotechnology.

Dr. Simos Simeonidis, Managing Partner and Co-Founder of Kos, emphasized the unique qualities that make FORTH an exemplary setting for biotech innovation. He noted that biotechnology thrives best in environments where deep scientific expertise is readily available and surrounded by a robust academic community. Drawing parallels to the biotech ecosystems that flourished in locations such as Boston, San Francisco, and San Diego, Dr. Simeonidis expressed confidence that the FORTH campus possesses the necessary infrastructure, facilities, and collective knowledge needed to foster a successful biotech ecosystem in Greece.

According to Dr. Simeonidis, “Our aim is to infuse the FORTH community with international biotechnology expertise, and to cultivate close collaborations between local researchers and global biotech companies. By integrating Kos's extensive investment pipeline with FORTH's exceptional research capabilities, we are laying the groundwork for an ecosystem poised to transform academic biological research into commercially viable therapeutics and technologies.”

Echoing similar sentiments, Professor Vassilis Charmandaris, Chairman of the Board of Directors at FORTH, highlighted the long-standing vision of the institute to drive scientific advancements that contribute to society and the economy. He articulated how the collaboration with Kos unlocks access to cutting-edge ideas and technologies from the leading US biotech sector, which will bolster FORTH's capabilities. “This partnership opens doors for innovative biotechnology companies that Kos has invested in globally, while simultaneously promoting homegrown ventures,” he stated.

The formation of this partnership marks a pivotal moment for the Greek biotech landscape, as it positions Greece not only to participate but to contribute meaningfully to the global biotechnology revolution. By attracting international biotech startups and nurturing local talent, Kos and FORTH are poised to ignite a new era of biotechnology in the region, one filled with potential breakthroughs in health and life sciences.

Kos Biotechnology Partners, a prominent life sciences investment firm with operations in New York and Athens, boasts a portfolio of approximately $125 million across various sectors within biotechnology. The firm's focus includes supporting therapeutic innovations and tech-enabled pharmaceutical services, thereby connecting emerging companies with valuable resources and expertise.

Meanwhile, FORTH stands as one of Greece's leading research institutions, recognized for its commitment to high-quality scientific work and advanced research facilities. The coordination of talents and resources between these two entities is set to fuel groundbreaking advancements in biotechnology and related fields, carving out a space for Greece on the global stage.

With the launching of this incubator, both Kos and FORTH signal their commitment to nurturing the next generation of biotech innovators in an environment that fosters collaboration, creativity, and scientific discovery. The synergy between their shared goals indicates a bright future for biotechnology in Greece, where local and international efforts can converge to create impactful health solutions for society as a whole.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.